Dr. Hildebrand is CEO of Nantiox, a local startup working on nanotechnology to prevent blindness caused by retinal diseases such as age-related macular degeneration, glaucoma and diabetic retinopathy.
He and Jim McGinnis, MD, professor of ophthalmology at the University of Oklahoma Health Sciences Center and lead researcher on the project, have been quite successful securing state and federal grants for the company.
Related Articles on Medical Innovation:
LA Times: Patients Should Research Ties Between Physicians and Drug Firms
Microscope Can See in Nano-Detail Using Algorithm Like Hubble Telescope’s
New Gas Connector Reduces Risk of Misconnection
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.